Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Wockhardt Limited
Press Release Dec 11 2023
Business
Dec 11 2023
3 min read

Press Release Dec 11 2023

Wockhardt Limited has informed the Exchange regarding a press release dated December 11, 2023, titled "Wockhardt announces successful completion of pivotal Phase 3 pneumonia study of its macrolide antibiotic Nafithromycin WCK 4873.".

View Attachment